EPO reimbursement
Executive Summary
Senate Finance Committee is considering a provision to provide Medicare reimbursement of home-administration of erythropoeitin (Amgen's Epogen) in its budget reconciliation package. Medicare currently covers the cost of administration of the drug in kidney dialysis centers ("The Pink Sheet" Sept. 18, T&G-3).